highly significantp < 0.0000
When stratified by disease stage, individuals diagnosed at Stage I–III ( n = 142) exhibited significantly more favorable survival trends than those with Stage IV tumors ( n = 36), with highly significant survival differences ( p < 0.0000; Figure S3 ).